1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Instruments & Supplies
The Cooper Companies, Inc.

The Cooper Companies, Inc.

COO
The Cooper Companies, Inc.US flagNASDAQ Global Select
76.53
USD
-0.07
- -
14.93BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
8.27
8.92
9.31
10.08
10.96
12.87
13.51
12.38
14.82
16.78
18.14
19.52
20.89
21.57
Basic EPS, GAAP
1.54
1.4
1.05
1.4
1.91
0.71
2.38
1.21
14.93
1.96
1.49
1.97
1.91
1.2
Free Cash Flow per Basic Share
1.24
1.13
0.77
1.83
2.39
2.42
2.14
0.9
2.66
2.28
1.09
1.44
2.21
2.9
Dividend per Share
0.02
0.01
0.02
0.01
0.01
0.01
0.02
0.02
0.02
0.02
0.02
- -
- -
- -
Book Value per Share
12.52
13.35
13.82
13.81
16.27
16.81
18.47
19.47
35.2
36.38
38.12
40.5
42.06
42.27
Tangible Book Value per Share
4.26
-0.54
0.31
0.46
1.62
-3.08
-1.05
0.45
15.7
8.52
11.19
12.29
14.29
14.65
Basic Weighted Avg Shares
192
193
193
195
195
197
196
196
197
197
198
200
196
196
Sales/Revenue/Turnover
1,588
1,718
1,797
1,967
2,139
2,533
2,653
2,431
2,922
3,308
3,593
3,895
4,092
4,231
Operating Margin (%)
21.48
17.84
13.17
16.48
20.06
16.88
19.9
12.83
17.31
15.34
14.84
18.12
16.69
11.77
Depreciation Expense
125
138
191
198
188
275
281
287
309
346
368
375
377
385
Net Income, GAAP
296
270
204
274
373
140
467
238
2,945
386
294
392
375
236
Effective Tax Rate (%)
4.92
8.33
4.83
7
5.36
57.85
2.24
10.54
- -
18.83
28.75
32.63
33.82
42.84
Profit Margin (%)
18.65
15.71
11.32
13.93
17.43
5.52
17.59
9.81
100.76
11.66
8.19
10.07
9.16
5.57
Working Capital
426
349
273
394
557
554
53
270
733
253
736
929
994
495
LT Debt
302
1,281
1,105
1,107
1,149
1,986
1,263
1,621
1,398
2,351
2,524
2,550
2,458
1,861
Total Equity
2,423
2,588
2,674
2,696
3,176
3,308
3,629
3,825
6,942
7,175
7,551
8,084
8,239
8,239
Return on Invested Capital (%)
12.12
8.34
5.63
7.49
9.72
3.73
9.6
4.93
- -
4.5
3.8
4.59
4.24
2.65
Return on Capital (%)
11.36
8.17
5.48
7.38
9.66
3.61
9.89
4.78
- -
4.71
3.68
4.52
4.12
2.68
Return on Common Equity (%)
12.88
10.85
7.77
10.21
12.7
4.32
13.46
6.4
54.7
5.47
4
5.02
4.59
2.85

Capital Structure

FRC

•

in mil. unless spec.
Oct'25
Jan'26
Apr'26
ST Debt
48
621
599
LT Borrowings
2,456
1,877
1,860
LT Finance Leases
2
2
2
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
196
195
195
Market Capitalization
13,695
15,877
12,260

Working Capital

FRC

•

in mil. unless spec.
Oct'25
Jan'26
Apr'26
Total Current Assets
2,106
2,134
2,300
Cash, Cash Equivalents & STI
111
125
139
Accounts Receivable, Net
829
807
809
Inventories
846
876
896
Total Current Liabilities
1,113
1,596
1,805
Payables & Accruals
300
226
558
ST Debt
48
621
599
Deferred Revenue
128
130
128

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
13.69%
19.81%
1.92%
Free Cash Flow
32.01%
43.14%
50.54%
Net Income, GAAP
124.64%
210.69%
-4.44%
Sales/Revenue/Turnover
8.85%
11.1%
5.06%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
932
943
1,003
1,018
3,895
2025
965
1,002
1,060
1,065
4,092
2026
1,024
1,082
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.41
0.45
0.53
0.59
1.97
2025
0.52
0.44
0.49
0.43
1.91
2026
0.67
-0.4
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

APIChatGPT
CEO
Albert G. White
Full Time Employees
15,000
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Address
6101 Bollinger Canyon Road San Ramon CA United States of America 94583
IPO Date
Jan 21, 1983
CIK
0000711404
Website
coopercos.com
Similar Companies
Tobii Dynavox AB (publ) (TDVOX.ST)
PlexBio Co., Ltd. (6572.TWO)
Well Lead Medical Co., Ltd. (603309.SS)
Repligen Corporation (RGEN)
INSPECS Group plc (SPEC.L)
Bioservo Technologies AB (publ) (BIOS.ST)
Business
The Cooper Companies, Inc. (Nasdaq: COO) develops, manufactures, and markets a broad range of medical devices focused on vision care and women's health. The company operates through two primary business units: CooperVision, which produces soft contact lenses including daily, two-week, and monthly disposables for spherical, toric, multifocal, and presbyopia correction; and CooperSurgical, which provides fertility products, genomic solutions, contraception devices, reproductive care tools, birth-related instruments, women's and family health diagnostics, office and surgical devices such as INSORB staplers, Lone Star retractors, and Doppler blood flow monitors. Products are distributed to eye care practitioners, healthcare professionals, hospitals, clinics, group purchasing organizations, and authorized resellers worldwide. Founded in 1958 and headquartered in San Ramon, California, the company employs over 16,000 people across 130 countries in Europe, Asia, Africa, and the Americas. In August 2024, CooperSurgical acquired obp Surgical for approximately $100 million, adding the ONETRAC portfolio of single-use cordless surgical retractors with integrated multi-LED lighting and smoke evacuation, as well as cordless suction devices with radial LED lights, which generated $14.5 million in trailing twelve-month revenue and complement existing surgical offerings. This acquisition, expected to be neutral to non-GAAP earnings per share in fiscal 2024 and accretive thereafter, underscores ongoing strategic expansion in women's health and surgical devices; additionally, in September 2025, the board authorized a $2 billion stock repurchase program representing up to 15.4% of outstanding shares.

Company News

APIChatGPT

  • gurufocus.com

    Minesto adapts organization to strengthen customer service offering

  • techcrunch.com

    Brad Lightcap, OpenAI's longtime COO, is leaving to ‘start something new'

  • gurufocus.com

    Motorola Solutions Inc (MSI) (Q2 2026) Earnings Call Highlights: Record Sales and Raised Guidance Signal Strong Momentum

  • gurufocus.com

    Global Payments Inc (GPN) (Q2 2026) Earnings Call Highlights: Strong EPS Growth and Strategic Progress Amid Middle East Headwinds

  • gurufocus.com

    Assurant Inc (AIZ) (Q2 2026) Earnings Call Highlights: Record Results Driven by Connected Living and Strategic Wins

  • zacks.com

    The Cooper Companies (COO) Upgraded to Buy: Here's What You Should Know

  • zacks.com

    COO vs. MMSI: Which Stock Should Value Investors Buy Now?

  • gurufocus.com

    Emerson Electric Co (EMR) (Q3 2026) Earnings Call Highlights: Strong Growth and Raised Guidance Amid Market Challenges

  • gurufocus.com

    Arista Networks Inc (ANET) (Q2 2026) Earnings Call Highlights: Record $3 Billion Quarter and Raised 2026 Guidance Signal Strong AI Momentum

  • gurufocus.com

    Williams Companies Inc (WMB) (Q2 2026) Earnings Call Highlights: Raises Guidance and Boosts Long-Term Growth Target to 11% CAGR

  • globenewswire.com

    CooperCompanies Announces Release Date for Third Quarter 2026

  • gurufocus.com

    MGM Resorts International (MGM) (Q2 2026) Earnings Call Highlights: Record Revenue and Digital Growth Amidst Las Vegas Challenges

  • zacks.com

    Why The Cooper Companies (COO) is a Top Value Stock for the Long-Term

  • businessinsider.com

    Chipotle's COO uses team dinners to spot potential leaders. These are the 4 qualities he looks for.

  • pymnts.com

    SEC Names JPMorgan Veteran Paul Knight as COO

  • gurufocus.com

    The Cooper Companies Inc (COO) Shares Surge 3.1% -- What GF Score of 84 Tells Investors

  • globenewswire.com

    New Era Energy & Digital Announces Leadership Transition to Support Next Phase of Execution and Growth

  • globenewswire.com

    CooperCompanies Releases 2025 Corporate Sustainability Report with Scope 3 Emissions Disclosure

  • zacks.com

    How COO Is Balancing Premium Lens Growth Against Asia-Pacific Risks?

  • zacks.com

    How COO Is Riding Myopia and Fertility Trends Amid Execution Risks